retatrutide making me feel sick Use of an unapproved triple-hormone receptor agonist bought online led to extreme side effects stemming from intractable diarrhea in a man who obtained the drug online from a direct-to-customer seller. The patient Tirzepatide vs. Retatrutide: Key Differences

The Future of GLP-1 Treatment The goal of these innovations is to make GLP-1 therapy more accessible, comfortable, and effective for a broad range of adults seeking to improve their health and confidence

Sanofi focuses on developing next-generation peptide therapeutics and forming alliances with biotech firms to enhance metabolic disease treatment options

Abstract Tirzepatide, a dual agonist for glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, has shown robust efficacy in treating diabetes and obesity, and in obese patients with heart failure with preserved ejection fraction (HFpEF), it reduced weight, lowered blood pressure, and improved outcomes

Use it in combination with other things, and it can be the most remarkable thing

The dose is 100200 mg IM, 2-3x per week